Author

Joshua Michlin

University of Colorado AnschutzORCID 0009-0002-1725-8481Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam L. GreeniD· 1 shared Ammu SureshiD· 1 shared Andrew M. DonsoniD· 1 shared Angela M. PierceiD· 1 shared Breauna BruntiD· 1 shared Bridget L. SanfordiD· 1 shared Dong WangiD· 1 shared Etienne P. DanisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam L. GreenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Diffuse Midline Glioma with a novel anti-CD99 Antibody

Ilango Balakrishnan, Krishna P.C. Madhavan, Angela M. Pierce, Joshua Michlin, Breauna Brunt, Senthilnath Lakshmanachetty, Dong Wang, John A. DeSisto, Zachary James Nuss, Nathan L. Davidson, Faye M. Walker, Ammu Suresh, Andrew M. Donson, Bridget L. Sanford, Kenneth L. Jones, , Sujatha Venkataraman

This paper identifies CD99 as a therapeutic target in K27M+DMGs, showing that a novel anti-CD99 antibody reduces tumor growth and enhances radiation efficacy in preclinical models.

Cancer Research · May 27, 2025Peer-reviewedCancer Biology